KLOW 80mg

Description

Composition: GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg), KPV (10 mg) — Total 80 mg

KLOW is a comprehensive regenerative and anti-inflammatory blend formulated to target tissue repair, cellular rejuvenation, and systemic inflammation simultaneously. Each component contributes a distinct mechanism—collagen synthesis, angiogenesis, cellular migration, and immune modulation—producing a full-spectrum recovery response.

Mechanism of Action:

• GHK-Cu → Stimulates fibroblast activity, collagen and elastin synthesis, and extracellular matrix remodeling.
• BPC-157 → Enhances angiogenesis and fibroblast migration for accelerated structural tissue repair.
• TB-500 → Promotes cellular migration and wound healing through actin polymerization modulation.
• KPV → Suppresses pro-inflammatory cytokines and modulates systemic immune balance.

Research Highlights:

Preclinical data support accelerated tissue healing, reduced inflammatory markers, and improved cellular recovery rates across musculoskeletal and dermal research models.

References: PMID 31469868 | 27094199 | 27612718

Potential Applications (for research use):

• Muscle and tendon regeneration models
• Skin, vascular, and dermal repair research
• Anti-inflammatory and systemic recovery protocols

Stacking Callouts:

Can be combined with Tesamorelin or Ipamorelin for metabolic recovery protocols, or with NAD⁺ for cellular-energetics optimization.

For laboratory and research use only. Not for human consumption.